Acute kidney injury predicts mortality in very elderly critically-ill patients

IF 5.9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
{"title":"Acute kidney injury predicts mortality in very elderly critically-ill patients","authors":"","doi":"10.1016/j.ejim.2024.05.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The increasing admissions of very elderly patients to intensive care units (ICUs) over recent decades highlight a growing need for understanding acute kidney injury (AKI) in this population. Although these individuals are potentially at high risk for AKI and adverse outcomes, data on AKI in this population is scarce. This study investigates the AKI incidence and outcomes of critically-ill patients aging at least 90 years.</p></div><div><h3>Methods</h3><p>This retrospective cohort study conducted at the Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Germany (2008–2020), investigates AKI incidence and outcomes between 2008 and 2020 in critically-ill patients aged ≥ 90 years. AKI was defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria using creatinine dynamics and/or urine output. Primary endpoint was overall mortality after 1 year. Secondary endpoints were in-hospital mortality, length of ICU and hospital stay.</p></div><div><h3>Results</h3><p>During the study period 92,958 critically-ill patients were treated and 1108 were ≥ 90 years. Of these, 1054 patients had available creatinine values and were included in the present study. AKI occurred in 24.4%, mostly classified as mild (17.5%). AKI was independently associated with a significant increase in overall mortality (HR 1.21, 95 %-CI: 1.01–1.46), in-hospital mortality (OR 2, 1.41–2.85), length of ICU (+2.8 days, 2.3–3.3) and hospital stay (+2.3 days, 0.9–3.7). Severity escalated these effects, but even mild AKI showed significance. Introducing urine-based criteria increased incidence but compromised mortality prediction.</p></div><div><h3>Conclusions</h3><p>AKI is a frequent complication in very elderly critically-ill patients. Occurrence of AKI at any stage was associated with increased mortality. Predictive ability applied to AKI defined by creatinine but not urine output. Careful attention of creatinine dynamics is essential in very elderly ICU-patients.</p></div>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":5.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0953620524001936/pdfft?md5=6515fceb6fccd7f1a0f2c0be605fbdbb&pid=1-s2.0-S0953620524001936-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0953620524001936","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The increasing admissions of very elderly patients to intensive care units (ICUs) over recent decades highlight a growing need for understanding acute kidney injury (AKI) in this population. Although these individuals are potentially at high risk for AKI and adverse outcomes, data on AKI in this population is scarce. This study investigates the AKI incidence and outcomes of critically-ill patients aging at least 90 years.

Methods

This retrospective cohort study conducted at the Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Germany (2008–2020), investigates AKI incidence and outcomes between 2008 and 2020 in critically-ill patients aged ≥ 90 years. AKI was defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria using creatinine dynamics and/or urine output. Primary endpoint was overall mortality after 1 year. Secondary endpoints were in-hospital mortality, length of ICU and hospital stay.

Results

During the study period 92,958 critically-ill patients were treated and 1108 were ≥ 90 years. Of these, 1054 patients had available creatinine values and were included in the present study. AKI occurred in 24.4%, mostly classified as mild (17.5%). AKI was independently associated with a significant increase in overall mortality (HR 1.21, 95 %-CI: 1.01–1.46), in-hospital mortality (OR 2, 1.41–2.85), length of ICU (+2.8 days, 2.3–3.3) and hospital stay (+2.3 days, 0.9–3.7). Severity escalated these effects, but even mild AKI showed significance. Introducing urine-based criteria increased incidence but compromised mortality prediction.

Conclusions

AKI is a frequent complication in very elderly critically-ill patients. Occurrence of AKI at any stage was associated with increased mortality. Predictive ability applied to AKI defined by creatinine but not urine output. Careful attention of creatinine dynamics is essential in very elderly ICU-patients.

急性肾损伤可预测高龄危重病人的死亡率。
背景:近几十年来,越来越多的高龄患者入住重症监护病房(ICU),这凸显出人们越来越需要了解这类人群的急性肾损伤(AKI)。尽管这些人可能是急性肾损伤和不良后果的高危人群,但有关该人群急性肾损伤的数据却很少。本研究调查了年龄至少在 90 岁以上的重症患者的 AKI 发生率和结果:这项回顾性队列研究在德国汉堡-埃彭多夫大学医疗中心重症医学科进行(2008-2020 年),调查了 2008 年至 2020 年间年龄≥90 岁的重症患者的 AKI 发生率和预后。AKI 根据肾脏疾病:改善全球预后 (KDIGO) 标准,使用肌酐动态变化和/或尿量来定义 AKI。主要终点是一年后的总死亡率。次要终点为院内死亡率、重症监护室和住院时间:在研究期间,92958 名重症患者接受了治疗,1108 名患者的年龄≥ 90 岁。其中,1054 名患者有肌酐值,被纳入本研究。24.4%的患者出现了 AKI,其中大部分为轻度 AKI(17.5%)。AKI 与总死亡率(HR 1.21,95 %-CI:1.01-1.46)、院内死亡率(OR 2,1.41-2.85)、重症监护室时间(+2.8 天,2.3-3.3)和住院时间(+2.3 天,0.9-3.7)的显著增加密切相关。严重程度增加了这些影响,但即使是轻度 AKI 也有显著影响。引入基于尿液的标准增加了发病率,但影响了死亡率预测:结论:AKI 是高龄危重病人的常见并发症。结论:AKI 是高龄重症患者的常见并发症,在任何阶段发生 AKI 都会增加死亡率。预测能力适用于以肌酐而非尿量定义的 AKI。对于高龄重症监护病房患者来说,密切关注肌酐动态变化至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Internal Medicine
European Journal of Internal Medicine 医学-医学:内科
CiteScore
9.60
自引率
6.20%
发文量
364
审稿时长
20 days
期刊介绍: The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信